Methanthelinium Bromide
Brand names,
Methanthelinium Bromide
Analogs
Methanthelinium Bromide
Brand Names Mixture
Methanthelinium Bromide
Chemical_Formula
C21H26NO3
Methanthelinium Bromide
RX_link
No information avaliable
Methanthelinium Bromide
fda sheet
Methanthelinium Bromide
msds (material safety sheet)
Methanthelinium Bromide
Synthesis Reference
No information avaliable
Methanthelinium Bromide
Molecular Weight
340.436 g/mol
Methanthelinium Bromide
Melting Point
No information avaliable
Methanthelinium Bromide
H2O Solubility
No information avaliable
Methanthelinium Bromide
State
Solid
Methanthelinium Bromide
LogP
No information avaliable
Methanthelinium Bromide
Dosage Forms
Tablet (50 mg)
Methanthelinium Bromide
Indication
For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.
Methanthelinium Bromide
Pharmacology
Methantheline is a synthetic quarternary ammonium antimuscarinic used to relieve cramps or spasms of the stomach, intestines, and bladder. It can be used together with antacids or other medicines, such as H2-receptor antagonists, in the treatment of peptic ulcer. Methantheline inhibits muscarinic actions at postganglionic parasympathetic neuroeffector sites.
Methanthelinium Bromide
Absorption
Rapidly absorbed.
Methanthelinium Bromide
side effects and Toxicity
Symptoms of overdose: blurred vision (continuing) or changes in near vision, clumsiness or unsteadiness, confusion, convulsions, difficulty in breathing, muscle weakness (severe), or tiredness (severe), dizziness, drowsiness (severe), dryness of mouth, nose, or throat (severe), fast heartbeat, fever, hallucinations, slurred speech, unusual excitement, nervousness, restlessness, or irritability, unusual warmth, dryness, and flushing of skin.
Methanthelinium Bromide
Patient Information
No information avaliable
Methanthelinium Bromide
Organisms Affected
Humans and other mammals